PS
IDYA icon

Principal Securities’s IDEAYA Biosciences IDYA Stock Holding History

Principal Securities’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-908
Closed -$24.7K – 2375
2025
Q3 		$24.7K Buy
908
+741
+444% +$17.9K ﹤0.01% 2312
2025
Q2 		$3.51K Buy
167
+23
+16% +$441 ﹤0.01% 2973
2025
Q1 		$3.7K Hold
144
– – ﹤0.01% 2880
2024
Q4 		$3.7K Buy
144
+31
+27% +$878 ﹤0.01% 2876
2024
Q3 		$3.58K Buy
113
+59
+109% +$2.24K ﹤0.01% 2784
2024
Q2 		$1.9K Buy
54
+22
+69% +$871 ﹤0.01% 2927
2024
Q1 		$1.4K Buy
+32
New +$1.38K ﹤0.01% 2960

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Principal Securities's IDYA Position: Q4 2025 in Review

Principal Securities sold out of IDEAYA Biosciences (IDYA) in Q4 2025, closing a stake of 908 shares — an estimated $24.7K sold.

Principal Securities first reported a position in IDYA in Q1 2024 and held it in 7 quarters. The position peaked at $24.7K in Q3 2025. 246 funds tracked by Wall St. Rank hold IDYA as of Q4 2025.

  • Principal Securities reported no remaining IDEAYA Biosciences position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 908 IDEAYA Biosciences shares in Q4 2025, an estimated $24.7K.
  • Principal Securities first reported a position in IDEAYA Biosciences in Q1 2024 and held it in 7 quarters.
  • Principal Securities's IDEAYA Biosciences position peaked at $24.7K in Q3 2025.
  • 246 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.